Skip to main content

Donate Today

Every gift, no matter the size, helps change children’s lives.

Nicholas F. Evageliou, MD

Nicholas F. Evageliou, MD

Nicholas F. Evageliou, MD

Nicholas F. Evageliou, MD, is an attending physician at CHOP’s Cancer Center with a special interest in kidney tumors in children, but with a broad clinical practice including liquid and solid tumors.

Areas of expertise: Kidney tumors, Neuroblastoma, Solid tumors

Locations: Specialty Care & Surgery Center, Voorhees, Specialty Care, Princeton at Plainsboro


215-590-3025

267-426-0762

About Nicholas F. Evageliou, MD

I provide care for a broad range of oncology and hematology conditions in our suburban clinic in Voorhees, New Jersey. Our patients benefit from a small, approachable and welcoming clinic in a suburban setting that also is linked to the world-class medical expertise, clinical research and state-of-the-art facilities at Children's Hospital in Philadelphia. Our team spends a significant amount of time answering questions and explaining complicated treatments, and we work hard to provide treatment for almost all cancers treated at the main hospital in Philadelphia.

While I maintain a clinical expertise with liquid tumors, my specific research interest is in solid tumors and kidney tumors in particular. My past research experience also includes work on neuroblastoma.

Titles

Attending Physician

Professor of Clinical Pediatrics in Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania

Certifications

Pediatric Hematology-Oncology – American Board of Pediatrics

Pediatrics – American Board of Pediatrics

Awards and Honors

2022, Philadelphia Magazine's Top Doctors in Pediatric Hematology-Oncology
2022, SJ Mag's Top Docs in Hematology/Oncology
2014-2015, 2022, South Jersey Magazine's Top Physicians in Pediatric Hematology-Oncology
2002, Lyman M. Stowe Award, University of Connecticut
2001, Sylvia Bodak Memorial Scholarship Award, University of Connecticut
2000-2002, Hellenic Medical Society of New York Award and Scholarship
1998-2002, University of Connecticut Health Center Auxiliary Award

Leadership and Memberships

Memberships in Professional Organizations

International

2006-present, Children’s Oncology Group
- 2014, Member of Renal Tumors Committee

National

2006-present, American Society of Pediatric Hematology and Oncology

Editorial and Academic Positions

Academic and Institutional Committees

2015-present: AAP PREP Hematology/Oncology Editorial Board
2014-present, COG Renal Tumors Committee
2014-present, CHOP Intern Selection Committee

Research Interests

Kidney tumors

Education & training

Medical Degree

MD - University of Connecticut School of Medicine, Farmington, CT

Internship

Pediatrics - The Children's Hospital of Philadelphia, Philadelphia, PA

Residency

Pediatrics - The Children's Hospital of Philadelphia, Philadelphia, PA

Fellowship

Hematology/Oncology - The Children's Hospital of Philadelphia, Philadelphia, PA

Team affiliations

View fewer team affiliations View all team affiliations

Publications

Publications

2016

Evageliou NF, Haber M, Vu A, Laetsch TW, Murray J, Cheng NC, Liu X, Reese M, Corrigan KA, Vido M, Ziegler D, Hayes C, Pawel B, Marshall GM, Zhao H, Gilmour SK, Norris MD, Hogarty MD. Polyamine antagonist therapies prevent neuroblastoma initiation and lethal progression. Clin Cancer Res. 2016 Mar 24. pii: clincanres.2539.2015. [Epub ahead of print]

Editorials, Reviews, Chapters

Wallis E, Evageliou N. Neuroblastoma. In: Florin T, Ludwig S, editors. Netter's pediatrics. Philadelphia: Saunders Elsevier; 2011.

Patient experience rating

(based on 35 submissions)

  • Clear Explanation
    4.8 of 5
  • Showed Concern
    4.8 of 5
  • Would recommend
    4.7 of 5
  • Discussion of Proposed Treatment
    4.7 of 5
Learn about the patient experience rating system

About the Patient Experience Rating System

The patient experience rating is an average of all responses to the care provider-related questions from surveys submitted by patient families and verified by our survey partner National Research Corporation (NRC Health), an independent company that specializes in patient experience. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question. Responses are measured using percent positive scoring. Percent positive is the percentage of respondents who answered with the most desirable response. We are committed to transparency and sharing the voices of our patients and families. Comments are reviewed before posting to ensure accuracy, privacy, and relevance. To provide meaningful feedback, comments are displayed on provider profiles once a sufficient number have been received. All feedback is also shared internally to support learning, recognition, and continuous improvement. The comments reflect the experiences and perspectives of the patients and families who submitted them. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.

Jump back to top